DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES
Clinical trials for DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES explained in plain language.
Never miss a new study
Get alerted when new DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES trials appear
Sign up with your email to follow new studies for DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New booster vaccine trial aims to shield japanese teens from three serious diseases
Disease control Recruiting nowThis study tests a single booster dose of a combined vaccine against diphtheria, tetanus, and whooping cough (dTpa) in 85 healthy Japanese adolescents aged 11 to 13. Researchers will check if the shot triggers a strong immune response and monitor for side effects one month after …
Matched conditions: DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
One shot in pregnancy could shield babies from whooping cough
Prevention Recruiting nowThis phase 3 trial will give a single dose of the dTpa vaccine (Boostrix) to 95 healthy Japanese pregnant women between 27 and 37 weeks of pregnancy. The goal is to see if the vaccine triggers strong immunity in the mothers and passes protective antibodies to their babies at birt…
Matched conditions: DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC